Agnes JUNG

Agnes Jung is a Senior Director of Clinical Programs in Early Oncology at AstraZeneca, bringing 20 years of extensive experience in clinical trials development and management. Previously, they held senior roles at Bridge Biotherapeutics, Inc., ICON plc, and Eli Lilly and Company, overseeing clinical operations, project management, and regulatory strategies. Agnes has led various global studies and managed cross-functional teams, enhancing operational efficiencies across multiple phases of clinical trials. They are currently pursuing a Bachelor's degree in Pharmacy and a Master's degree in Pharmaceutical Outcomes Research at Chung-Ang University, complementing their training at Harvard Medical School in clinical trials research.